| Dr Isabel B Brachfeld, EDD | |
|
440 Sussex Ave, Morristown, NJ 07960-3527 | |
| (973) 455-1352 | |
| (973) 285-1734 |
| Full Name | Dr Isabel B Brachfeld |
|---|---|
| Gender | Female |
| Speciality | Psychologist |
| Location | 440 Sussex Ave, Morristown, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013085687 | NPI | - | NPPES |
| 5037603 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103T00000X | Psychologist | SI02155 (New Jersey) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Isabel B Brachfeld, EDD 440 Sussex Ave, Morristown, NJ 07960-3527 Ph: (973) 455-1352 | Dr Isabel B Brachfeld, EDD 440 Sussex Ave, Morristown, NJ 07960-3527 Ph: (973) 455-1352 |
News Archive
Researchers at Columbia University Medical Center (CUMC) have identified the immune cells responsible for destroying hair follicles in people with alopecia areata, a common autoimmune disease that causes hair loss, and have tested an FDA-approved drug that eliminated these immune cells and restored hair growth in a small number of patients.
Among teen boys in urban neighborhoods with low resources, the presence of adult social support is linked to significantly fewer occurrences of sexual violence, youth violence and bullying, and to more positive behaviors, including school engagement and future aspirations, according to a new study from researchers at UPMC Children's Hospital of Pittsburgh and the University of Pittsburgh School of Medicine.
Some 61 million rural children left behind by parents moving to China's booming urban centres are at risk from increased fat and reduced protein in their diets, research from The University of Manchester, published in Public Health Nutrition suggests.
Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, today announced the dosing of the first patient under the Company's recently initiated Phase I clinical trial with SL052 Photodynamic Therapy in prostate cancer patients. The study will evaluate the localization, safety, tolerability and preliminary treatment response of SL052 photodynamic therapy in 18 patients with localized prostate cancer.
Merrimack Pharmaceuticals, Inc. announced today that the first patient has been dosed in a Phase 2 clinical trial of MM-121, a fully human monoclonal antibody that targets ErbB3, in combination with erlotinib, a small molecule directed at the epidermal growth factor receptor (EGFR), in three groups of patients with metastatic non-small cell lung cancer.
› Verified 1 days ago
Eric Steven Kirschner, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 95 Mt. Kemble Avenue, Morristown, NJ 07962 Phone: 973-971-4714 Fax: 973-290-7585 | |
Dr. Marian R Stuart, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 7 Harwich Rd, Morristown, NJ 07960 Phone: 973-267-3127 Fax: 732-246-8084 | |
Dr. Alexandra Morris, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 55 Madison Avenue, Suite 400, Office # 84, Morristown, NJ 07960 Phone: 973-671-8933 | |
Dr. Kelly Zbojovsky, PHD Psychologist Medicare: Not Enrolled in Medicare Practice Location: 55 Madison Ave, Suite 400, Office 83, Morristown, NJ 07960 Phone: 973-671-8933 | |
Dr. Aaron G Welt, PH.D. Psychologist Medicare: Medicare Enrolled Practice Location: 261 James St Ste 2c, Morristown, NJ 07960 Phone: 973-538-7490 | |
Diane Lynn Cabush, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 32 Maple Ave Fl 2, Morristown, NJ 07960 Phone: 973-539-7055 Fax: 973-267-5278 |